Li, Chenshuang
Zheng, Zhong
Ha, Pin
Jiang, Wenlu
Soo, Chia
Ting, Kang
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR066782, R01AR068835)
National Institute of Dental and Craniofacial Research (R03DE030400)
American Association of Orthodontists Foundation (Orthodontic Faculty Development Fellowship Award)
University of Pennsylvania School of Dental Medicine (Joseph and Josephine Rabinowitz Award for Excellence in Research)
Department of Orthodontics, University of Pennsylvania School of Dental Medicine (J. Henry O’Hern Jr. Pilot Grant)
International Orthodontics Foundation (2022 Research Grant)
Article History
Received: 20 June 2023
Accepted: 20 November 2023
First Online: 15 December 2023
Declarations
:
: All the experiments on live mice were performed under an institutionally approved protocol provided by the Chancellor’s Animal Research Committee at UCLA (protocol numbers: 2014-041 and 2013-013).
: Not applicable.
: C.L., Z.Z., C.S., and K.T. are inventors of Nell-1 related patents. C.S., and K.T. are also founders and/or past board members of Bone Biologics Inc./Bone Biologics Corp., who sublicense Nell-1 patents from the UC Regents, who also hold equity in the company. Bone Biologics Inc./Bone Biologics Corp. did not provide financial support for the current study.